Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 828 results for "hcv"

Forum for Collaborative HIV Research Release: National Summit ...

/PRNewswire-USNewswire/ --At a time when new cases of hepatitis C virus (HCV) infection are rising and HIV rates have reached epidemic levels in some rural communities, the Forum for Collaborative HIV Research will convene its 2015 National Summit ... BioSpace, Just now

67 images for hcv

Renal & Urology News, 6 days ago
European Automobile Manufacturers' Association, 19 hours ago
Tutorial Finder, 6 days ago
Global Information Inc, 23 hours ago, 3 days ago
MDLinx, 18 hours ago, 2 days ago
Times of India, 3 days ago, 1 week ago
Orthopedics Today, 1 week ago

Gilead Sciences, Inc. Goes Up As HCV Scripts Finally Recover; AbbVie Inc Falls Behind

Gilead Sciences, Inc. ( NASDAQ:GILD ) has finally managed to recover from the prolonged declining prescription volumes for its hepatitis C virus (HCV) drugs. The prescription volumes for Gilead's HCV franchise, Sovaldi and Harvoni, for the month of ...
 Bidness Etc17 hours ago

AbbVie's 2-DAA regimen achieves 95% cure rate in Japanese HCV-1b patients

News Editor A Phase 3 study, GIFT-1, evaluating AbbVie's (NYSE:ABBV) investigational, all-oral, interferon-free, ribavirin-free, two direct-acting (2-DAA) antiviral combination of ombitasvir/paritaprevir/ritonavir for the treatment patients with ...
 Seeking Alpha1 day ago AbbVie announces new results from Phase 3 GIFT-I study in GT1b HCV infected Japanese patients  News-Medical.Net1 day ago Enanta Announces SVR12 results of 95% from AbbVie's GIFT-1 Study in Non-cirrhotic, Japanese Patients with Genotype 1b Hepatitis C Virus(1)  Individual.com1 day ago AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis  Noodls1 day ago
Med India

Hepatitis C Virus (HCV) Protease Inhibitors -Pipeline Insights, 2015

Summary DelveInsight's, Hepatitis C Virus (HCV) Protease Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Hepatitis C Virus (HCV) Protease Inhibitors. The main objective of this report to track ...
 MarketResearch.com2 days ago Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study  Bionity.com2 days ago Simultaneously Targeting the NS3 Protease and Helicase Activities for More Effective Hepatitis C Virus Therapy  Bionity.com2 days ago New HCV Therapy Effective across Disease Spectrum  Oncology Times5 days ago

Gilead Sciences, Inc. (GILD) Facing Declining HCV Prescription Volumes For The Longest Period

Gilead Sciences, Inc. ( NASDAQ:GILD ) has been struggling with the prescription volumes for its HCV drugs, as prescriptions for Harvoni continue their downward trend throughout the month of May. The prescription volumes have continued to decline for ...
 Bidness Etc3 days ago Shake-up in key Samsung assets to cement heir's grip as succession looms  Mr Top Step2 days ago

Asia Pacific Exhaust System Market 2015-2019 - Fuel Type (Gasoline & Diesel) & Vehicle Type (Passenger Cars, LCV, HCV)

Research and Markets ( has announced the addition of the "Asia Pacific Exhaust System Market, by Fuel Type, By Vehicle Type And By Country- Trends And Forecast up to 2019" report to ...
 Individual.com1 week ago Asia Pacific Fuel Injection Systems Market 2015-2019 - Engine Type (Gasoline, Diesel) & Application (Passenger Car, LCV, HCV) Analysis  Individual.com1 week ago Automotive Engine Management System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2021  Individual.com5 hours ago Research and Markets: Automotive Engine Management System Market - Global Industry Analysis, Size, Share, Grow...  TeleTrader.com3 hours ago
American Banking News - Forex

Gilead, Merck And Achillion/J&J Square Off In An HCV 'Nuc'lear Showdown

12:33 PM ET | About: Gilead Sciences, Inc. (GILD), Includes: ACHN, JNJ, MRK by: Small Pharma Analyst Summary Comparison of 7-day monotherapy of Sovaldi vs MK-3682 (MRK) and ACH 3422 indicate a rate of viral clearance of Sovaldi > MK-3682 > ...
 Seeking Alpha6 days ago Pharmaceutical firm to invest $100M in Edmonton manufacturing site  Canadian ManufacturingJust now Gilead Will Hire Up to 170 Scientists in $100 Million Edmonton Expansion  BioSpace41 minutes ago Gilead Sciences, Inc. Plans To Expand Its Operations  Bidness Etc3 hours ago
Monthly Prescribing Reference

Bristol-Myers' HCV Combination Designation Amended by FDA - Analyst Blog

Bristol-Myers Squibb Company BMY announced that the FDA has amended its previously granted Breakthrough Therapy Designation for the investigational combination daclatasvir and Gilead Sciences GILD Sovaldi for use in hepatitis C (HCV) patients. ...
 Zacks.com6 days ago FDA amends Bristol-Myers' BTD tag for HCV-1 candidate  Seeking Alpha1 week ago Bristol-Myers gets amended FDA breakthrough therapy status for daclatasvir-based HCV regimen  Pharmaceutical Business Review1 week ago Investigational HCV Tx Receives Amended Breakthrough Designation  Monthly Prescribing Reference1 week ago

What Does The Johnson & Johnson/Achillion Deal Mean For HCV Competitors?

On Tuesdady, Johnson & Johnson (NYSE: JNJ) and Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) announced this week that they are entering into a collaboration agreement to develop one or more of Achillion's lead hepatitis C virus (HCV) treatments, ...
 Benzinga.com1 week ago Johnson & Johnson (JNJ) Announced 10 New Approval Applications with $1 Billion Revenue Potential Each 5/26/2015  ClinicSpace18 hours ago

Janssen collaborates with Achillion Pharma to develop & commercialize HCV products

Janssen Pharmaceuticals, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has entered into an exclusive worldwide license and collaboration arrangement with Achillion Pharmaceuticals, Inc. (Achillion) to develop and ...
 PharmaBiz1 week ago Janssen, Achillion in HCV Development Pact  Contract Pharma1 week ago ACHILLION PHARMACEUTICALS INC FILES (8-K) Disclosing Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits  Pharmacy Choice19 hours ago Janssen Pharmaceuticals enters into worldwide Hepatitis C collaboration with Achillion  Manufacturing Chemist1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - hcv
Get updated on latest news & your favorite topics right in your inbox!
More     Less